Jiangsu, China

Xiaojuan Diao




Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 25(Granted Patents)


Location History:

  • Suzhou, CN (2019)
  • Jiangsu, CN (2019 - 2020)

Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: **Xiaojuan Diao: Innovator in Pharmaceutical Crystallization**

Introduction

Xiaojuan Diao, hailing from Jiangsu, China, is a notable inventor with a focus on pharmaceutical innovations. With a portfolio comprising six patents, Xiaojuan has made significant contributions to the field of drug formulation and preparation, particularly in developing novel crystalline forms of key pharmaceutical compounds.

Latest Patents

Among Xiaojuan Diao's latest patents is the creation of a crystalline form of lenvatinib mesylate, along with an efficient process for its preparation. This innovative form is particularly relevant for treating invasive and differentiated thyroid cancer. Noteworthy attributes of this crystalline form include its excellent solubility, stability, and remarkable purification capabilities, making the preparation method not only simple and low-cost but also invaluable for future drug optimization.

Another significant patent of Xiaojuan involves the development of novel crystalline forms of JAK inhibitors. This invention holds promise for the treatment of autoimmune diseases, specifically rheumatoid arthritis. The crystalline forms exhibit good stability and purification effects, with solubility and hygroscopicity that meet the stringent requirements for medical applications. The preparation process remains straightforward and economically advantageous, enhancing its potential for further development in the pharmaceutical industry.

Career Highlights

Xiaojuan Diao is currently associated with Crystal Pharmatech Co., Ltd., where their work at the intersection of chemistry and medicine continues to yield innovative solutions addressing critical healthcare challenges. Their focus on crystalline drug development exemplifies a commitment to enhancing treatment effectiveness through improved pharmaceutical forms.

Collaborations

Collaboration plays a vital role in Xiaojuan's success. They work alongside talented colleagues such as Minhua Chen and Yanfeng Zhang, contributing diverse expertise to their innovative projects. These collaborative efforts enhance the quality of research and lead to the development of impactful pharmaceutical advancements.

Conclusion

Xiaojuan Diao's innovative work in creating novel crystalline forms of drugs exemplifies the potential of modern pharmaceutical research. With an emphasis on solubility, stability, and cost-effectiveness, Xiaojuan's patents are positioned to advance treatment options for serious health conditions. Their contributions continue to inspire advancements in the pharmaceutical industry, showcasing the vital role of inventors in developing effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…